Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. / van Eerd, Eva Anne Marije; Risor, Mette Bech; Spigt, Mark; Godycki-Cwirko, Maciek; Andreeva, Elena; Francis, Nick; Wollny, Anja; Melbye, Hasse; van Schayck, Onno; Kotz, Daniel.

In: npj Primary Care Respiratory Medicine, Vol. 27, No. 1, 41, 23.06.2017.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

van Eerd, EAM, Risor, MB, Spigt, M, Godycki-Cwirko, M, Andreeva, E, Francis, N, Wollny, A, Melbye, H, van Schayck, O & Kotz, D 2017, 'Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study', npj Primary Care Respiratory Medicine, vol. 27, no. 1, 41. https://doi.org/10.1038/s41533-017-0038-6

APA

van Eerd, E. A. M., Risor, M. B., Spigt, M., Godycki-Cwirko, M., Andreeva, E., Francis, N., Wollny, A., Melbye, H., van Schayck, O., & Kotz, D. (2017). Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. npj Primary Care Respiratory Medicine, 27(1), [41]. https://doi.org/10.1038/s41533-017-0038-6

Vancouver

van Eerd EAM, Risor MB, Spigt M, Godycki-Cwirko M, Andreeva E, Francis N et al. Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. npj Primary Care Respiratory Medicine. 2017 Jun 23;27(1). 41. https://doi.org/10.1038/s41533-017-0038-6

Author

van Eerd, Eva Anne Marije ; Risor, Mette Bech ; Spigt, Mark ; Godycki-Cwirko, Maciek ; Andreeva, Elena ; Francis, Nick ; Wollny, Anja ; Melbye, Hasse ; van Schayck, Onno ; Kotz, Daniel. / Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. In: npj Primary Care Respiratory Medicine. 2017 ; Vol. 27, No. 1.

Bibtex

@article{5e6e45f727004b65a6fc277127c7a534,
title = "Why do physicians lack engagement with smoking cessation treatment in their COPD patients?: A multinational qualitative study",
abstract = "Smoking cessation is the only effective intervention to slow down the accelerated decline in lung function in smokers with chronic obstructive pulmonary disease. Nevertheless, physicians often do not routinely provide evidence-based smoking cessation treatment to their patients. To understand underlying reasons, we explored how physicians engage in smoking cessation treatment in their chronic obstructive pulmonary disease patients. In total, 21 focus group discussions were held with general practitioners and pulmonologists in seven different countries in Europe and Asia. We generated three themes, whereby some of the issues concerned smokers in general: first, 'physicians' frustration with chronic obstructive pulmonary disease patients who smoke'. These frustrations interfered with the provision of evidence-based treatment and could result in this group of patients being treated unequally. Second: 'physicians' limited knowledge of, and negative beliefs about, smoking cessation treatment'. This hindered treating smokers effectively. Third: 'healthcare organisational factors that influence the use of smoking cessation treatments'. Money and time issues, as well as the failure to regard smoking as a disease, influenced how physicians engaged in smoking cessation treatment. Our results indicate that there is a number of barriers to the provision of effective smoking cessation treatment in patients with chronic obstructive pulmonary disease and smokers in general. Introducing an informative smoking cessation programme, including communication skills and ethical issues, in the vocational and postgraduate medical training may help to address these barriers. This is important in order to increase engagement with smoking cessation treatment and to improve quality of chronic obstructive pulmonary disease care.",
keywords = "OBSTRUCTIVE PULMONARY-DISEASE, PRIMARY-CARE, GENERAL-PRACTITIONERS, TOBACCO DEPENDENCE, SMOKERS, IMPLEMENTATION, INTERVENTIONS, PERSPECTIVES, EXPERIENCES, GUIDELINES",
author = "{van Eerd}, {Eva Anne Marije} and Risor, {Mette Bech} and Mark Spigt and Maciek Godycki-Cwirko and Elena Andreeva and Nick Francis and Anja Wollny and Hasse Melbye and {van Schayck}, Onno and Daniel Kotz",
year = "2017",
month = jun,
day = "23",
doi = "10.1038/s41533-017-0038-6",
language = "English",
volume = "27",
journal = "Npj Primary Care Respiratory Medicine",
issn = "2055-1010",
publisher = "nature publishing group",
number = "1",

}

RIS

TY - JOUR

T1 - Why do physicians lack engagement with smoking cessation treatment in their COPD patients?

T2 - A multinational qualitative study

AU - van Eerd, Eva Anne Marije

AU - Risor, Mette Bech

AU - Spigt, Mark

AU - Godycki-Cwirko, Maciek

AU - Andreeva, Elena

AU - Francis, Nick

AU - Wollny, Anja

AU - Melbye, Hasse

AU - van Schayck, Onno

AU - Kotz, Daniel

PY - 2017/6/23

Y1 - 2017/6/23

N2 - Smoking cessation is the only effective intervention to slow down the accelerated decline in lung function in smokers with chronic obstructive pulmonary disease. Nevertheless, physicians often do not routinely provide evidence-based smoking cessation treatment to their patients. To understand underlying reasons, we explored how physicians engage in smoking cessation treatment in their chronic obstructive pulmonary disease patients. In total, 21 focus group discussions were held with general practitioners and pulmonologists in seven different countries in Europe and Asia. We generated three themes, whereby some of the issues concerned smokers in general: first, 'physicians' frustration with chronic obstructive pulmonary disease patients who smoke'. These frustrations interfered with the provision of evidence-based treatment and could result in this group of patients being treated unequally. Second: 'physicians' limited knowledge of, and negative beliefs about, smoking cessation treatment'. This hindered treating smokers effectively. Third: 'healthcare organisational factors that influence the use of smoking cessation treatments'. Money and time issues, as well as the failure to regard smoking as a disease, influenced how physicians engaged in smoking cessation treatment. Our results indicate that there is a number of barriers to the provision of effective smoking cessation treatment in patients with chronic obstructive pulmonary disease and smokers in general. Introducing an informative smoking cessation programme, including communication skills and ethical issues, in the vocational and postgraduate medical training may help to address these barriers. This is important in order to increase engagement with smoking cessation treatment and to improve quality of chronic obstructive pulmonary disease care.

AB - Smoking cessation is the only effective intervention to slow down the accelerated decline in lung function in smokers with chronic obstructive pulmonary disease. Nevertheless, physicians often do not routinely provide evidence-based smoking cessation treatment to their patients. To understand underlying reasons, we explored how physicians engage in smoking cessation treatment in their chronic obstructive pulmonary disease patients. In total, 21 focus group discussions were held with general practitioners and pulmonologists in seven different countries in Europe and Asia. We generated three themes, whereby some of the issues concerned smokers in general: first, 'physicians' frustration with chronic obstructive pulmonary disease patients who smoke'. These frustrations interfered with the provision of evidence-based treatment and could result in this group of patients being treated unequally. Second: 'physicians' limited knowledge of, and negative beliefs about, smoking cessation treatment'. This hindered treating smokers effectively. Third: 'healthcare organisational factors that influence the use of smoking cessation treatments'. Money and time issues, as well as the failure to regard smoking as a disease, influenced how physicians engaged in smoking cessation treatment. Our results indicate that there is a number of barriers to the provision of effective smoking cessation treatment in patients with chronic obstructive pulmonary disease and smokers in general. Introducing an informative smoking cessation programme, including communication skills and ethical issues, in the vocational and postgraduate medical training may help to address these barriers. This is important in order to increase engagement with smoking cessation treatment and to improve quality of chronic obstructive pulmonary disease care.

KW - OBSTRUCTIVE PULMONARY-DISEASE

KW - PRIMARY-CARE

KW - GENERAL-PRACTITIONERS

KW - TOBACCO DEPENDENCE

KW - SMOKERS

KW - IMPLEMENTATION

KW - INTERVENTIONS

KW - PERSPECTIVES

KW - EXPERIENCES

KW - GUIDELINES

U2 - 10.1038/s41533-017-0038-6

DO - 10.1038/s41533-017-0038-6

M3 - Journal article

VL - 27

JO - Npj Primary Care Respiratory Medicine

JF - Npj Primary Care Respiratory Medicine

SN - 2055-1010

IS - 1

M1 - 41

ER -

ID: 278487214